Manufacturers, distributors and healthcare providers unite to address ongoing abuse
In the battle lines over the widespread problem of prescription drug abuse, there is some good news to report: the just-released National Survey on Drug Use and Health (NSDUH), from the US Substance Abuse and Mental Health Services Administration (SAMHSA), shows that in the 18-25 age category, prescription drug abuse has fell by 14% in 2011, amounting to 1.7 million. However, that form of abuse remained unchanged both in younger (12-17 years old) and older (26 and up). Across all age categories, the NSDUH finds that there are 6.1 million abusers of “psychotherapeutic drugs, including 4.5 million users of pain relievers, 1.8 million users of tranquilizers, 970,000 users of stimulants, and 231,000 users of sedatives.”
The scope of the problem has been recognized for years, and has grown even as abuse of illicit drugs like cocaine has fallen. The entire healthcare industry, from manufacturers to healthcare providers and pharmacies, is engaged. This week (Sept. 23-29) will see a variety of outreach efforts, especially those using social media, sponsored by The Medicine Abuse Project, an activity of The Partnership at DrugFree.Org, and culminating in a National Prescription Drug Take-Back Day on Sept. 29. Lead sponsors are Abbott, Cardinal Health Foundation, CVS Caremark, Mallinckrodt, and PhRMA. DEA is coordinating part of the activity, which will occur in many local and regional settings nationwide.
Besides outlining the size of the drug-abuse problem, the NSDUH highlights the gap between drug abusers seeking treatment, and those actually receiving it: 2.3 million out of 21.6 million, or 10.8% of those in need.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.